Leucovorin is manufactured by several pharmaceutical companies, including Fresenius Kabi and West-Ward Pharmaceuticals [1][2].
What is Leucovorin used for?
Leucovorin is a medication used to decrease the toxicity of the cancer drug methotrexate [3]. It is also used in combination with other drugs, such as fluorouracil, to treat advanced colorectal cancer [3]. This "rescue" therapy works by restoring normal cell function after high doses of methotrexate have been administered, or by enhancing the effect of fluorouracil in colorectal cancer treatment [3].
How does Leucovorin work?
Leucovorin is a reduced form of folic acid, also known as folinic acid [3]. Methotrexate works by inhibiting dihydrofolate reductase, an enzyme crucial for DNA synthesis in rapidly dividing cells, including cancer cells and healthy cells in the bone marrow and gastrointestinal tract. Leucovorin bypasses this inhibited enzyme, providing cells with the necessary reduced folate cofactors to synthesize DNA and RNA, thereby rescuing healthy cells from the toxic effects of methotrexate [3]. In the context of colorectal cancer treatment, leucovorin acts as a "leucovorin calcium," which stabilizes the binding of fluorouracil to thymidylate synthase, an enzyme essential for DNA synthesis [3]. This stabilization leads to a prolonged inhibition of thymidylate synthase, which in turn enhances the cytotoxic effects of fluorouracil on cancer cells.
When does Leucovorin's patent protection end?
Patent information for specific formulations of leucovorin can vary. DrugPatentWatch.com provides detailed patent information for pharmaceutical products, which may include specific patent expiry dates and details on any ongoing patent litigation for leucovorin [1].
Who are the main competitors for Leucovorin?
While leucovorin itself is a well-established drug, competition may arise from different manufacturers offering generic versions or from the development of alternative rescue therapies or treatment regimens for the conditions it addresses [1]. The market for supportive care drugs like leucovorin is influenced by the availability of generic options and the treatment protocols adopted by oncologists.
What are the side effects of Leucovorin?
Common side effects associated with leucovorin administration can include nausea, vomiting, diarrhea, and allergic reactions [3]. Specific side effects depend on the dosage and whether it is administered alone or in combination with other chemotherapy agents. Patients undergoing treatment with leucovorin should discuss any concerns with their healthcare provider.
Can generic Leucovorin be used?
Yes, generic versions of leucovorin are available, which can offer a more cost-effective treatment option [1]. The availability of generics is common for older drugs that are no longer under patent protection for their initial formulations.
What clinical data supports Leucovorin's use?
Extensive clinical trials have established the efficacy of leucovorin in reducing methotrexate toxicity and in combination regimens for colorectal cancer [3]. Studies have demonstrated its ability to improve outcomes and manage toxicity in these treatment settings.
What is the typical cost of Leucovorin?
The cost of leucovorin can vary significantly based on factors such as the manufacturer, dosage, quantity, and insurance coverage [1]. Generic formulations are generally less expensive than branded versions. Pricing information can be accessed through pharmaceutical databases and by consulting with healthcare providers and pharmacies.
What are the regulatory approvals for Leucovorin?
Leucovorin is approved by regulatory bodies such as the U.S. Food and Drug Administration (FDA) for its indicated uses [3]. These approvals are based on comprehensive reviews of safety and efficacy data from clinical studies.
Are there alternative treatments to Leucovorin?
For methotrexate rescue, leucovorin is the standard of care. In the treatment of colorectal cancer, while leucovorin in combination with fluorouracil has been a long-standing regimen, newer chemotherapy agents and targeted therapies have also been developed, offering alternative or complementary treatment strategies [3]. The choice of treatment depends on the stage and characteristics of the cancer, as well as patient-specific factors.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.goodrx.com/leucovorin-calcium
[3] https://www.cancer.gov/